Dr Shobhit Baijal
MBBS BSc (Hons), MRCP, MRCP (Medical Oncology) Level 4 Cancer Rehabilitation
I am a Consultant Medical Oncologist based at The University Hospital Birmingham NHS Trust. I obtained a BSc Honours in immunology and cell pathology from University College London, before graduating with a medical degree from St. Bartholomew’s Medical School in 2001. I then returned to the Midlands to complete my general medical and oncology training and took up post as Consultant Medical Oncologist in September 2011.
I actively treat lung, colorectal and liver cancer patients at the Heartlands, Good Hope and Solihull sites. I specialise in all forms of cancer drug treatments including chemotherapy, immuno-oncology, precision oncology and chemo-embolisation.
I have a large clinical trial portfolio and I am the UK Chief Investigator and Principle Investigator for national and international clinical trials. I am at the forefront of the clinical utility of liquid biopsy in managing lung and colorectal cancer patients and I have several studies underway in this context. I have numerous publications and regularly present at regional, national and international cancer meetings. I am on the BTOG Steering Committee and also sit on the advisory panel for the Roy Castle Lung Cancer Foundation.
I am extremely passionate about cancer survivorship and have developed and led on health and wellbeing clinics, having a specialist interested in the benefits of exercise for cancer patients and survivors.
I aim to deliver cutting edge, individualised and evidence based cancer treatments for his patients whilst ensuring their health and wellbeing is also prioritised.
COVID-19 testing or antibody tests are not available as a standalone service at Spire Little Aston Hospital.
MBBS BSc(Hons), MRCP, MRCP(Medical Oncology) Level 4 Cancer Rehabilitation / London / 2001
Bachelor of Medicine/Bachelor of Surgery, Bachelor of Science, Membership of the Royal College of Physicians
Royal College of Physician
Association of Cancer Physicians
European Society of Medical Oncology
Bowel cancer, lung cancer, hepato-biliary cancer, cancer of unknown primary, cancer rehabilitation